Pakistan Pharma Bureau Urges Pricing Decisions Consider All Drug Costs
This article was originally published in PharmAsia News
Pharma Bureau Pakistan is pressing the nation's government to consider all aspects of drug-pricing so the country does not adopt a policy that would lead to restricting the availability of essential drugs.
You may also be interested in...
BD and BioMedomics have released a new rapid point-of-care test that can detect antibodies in blood to confirm current or past exposure to COVID-19.
Experts think GLP-1s in neurodegeneration may be Novo Nordisk’s next opportunity and await readouts from the Phase II ELAD trial in Alzheimer's disease for signals.
France has announced a number of emergency measures to protect drug supplies threatened by the spread of the coronavirus.